There are several pipeline items in the half year releases that sound very promising and I hadn't seen in prior announcements...
Gamma camera PSMA product (ie allows prostate cancer staging in places that do not have a PET camera).
Radiomuclide therapy for multiple myeloma (alpha therapy so much much more effective)
Expanded role for the TLX-250cdx PET tracer for non-RCC cancer
novel use of PSMA bound to a visible dye so that surgeons can literally see fluorescent light showing the prostate cancer during the op.
PSMA based alpha therapy for metastatic prostate cancer.
A lot of novel and great ideas coming up!!
Great also to see a lot of Australian involvement in the pipeline. Australia is one of the leading nations for pushing the boundaries of theranostics / radionuclide therapy.
- Forums
- ASX - By Stock
- TLX
- Ann: Half Year Shareholder Update
Ann: Half Year Shareholder Update, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.44 |
Change
-0.320(1.54%) |
Mkt cap ! $6.840B |
Open | High | Low | Value | Volume |
$20.79 | $21.00 | $20.22 | $19.41M | 945.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $20.42 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.46 | 45 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 20.420 |
1 | 2000 | 20.330 |
1 | 250 | 20.250 |
1 | 495 | 20.230 |
1 | 1000 | 20.200 |
Price($) | Vol. | No. |
---|---|---|
20.630 | 3000 | 1 |
20.750 | 2000 | 1 |
20.970 | 143 | 1 |
20.990 | 1550 | 2 |
21.000 | 9256 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |